PHYSIOVISIT
The computed 12-month bankruptcy probability of PHYSIOVISIT is 0.3% (very low). The 2024 annual accounts show equity of €29k and a net result of €9k. Equity is growing by ~59.3% per year across the filed fiscal years. Its solvency ranks better than 49% of 800 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €29k |
| Net result | €9k |
| Better than sector | 49% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 38.6% | 40.7% | |
| Net result | €9k | €7k | |
| Equity | €29k | €20k | |
| Gross operating margin | €30k | €18k | |
| Staff costs | €2k | €17k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €27k |
| Net profit | €9k |
| Cash flow | €21k |
| Staff costs | €2k |
| Income taxes | €4k |
| Dividends | - |
| Total assets | €74k |
| Equity | €29k |
| Debt | €45k |
| of which ≤ 1y | €19k |
| of which > 1y | €26k |
| Working capital | €-187 |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.99 |
| Quick ratio | 0.99 |
| Working capital ratio | -0.3% |
| Solvency | 38.6% |
| Debt / equity | 1.59 |
| Long-term debt ratio | 0.92 |
| Interest coverage | 9.04 |
| Gross margin | - |
| Net margin | - |
| ROA | 12.2% |
| ROE | 31.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €74k |
| Fixed assets | 21/28 | €56k |
| Tangible fixed assets | 22/27 | €56k |
| Current assets | 29/58 | €18k |
| Amounts receivable within one year | 40/41 | €3k |
| Cash & bank | 54/58 | €16k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €74k |
| Equity | 10/15 | €29k |
| Contributions / capital | 10/11 | €8k |
| Reserves | 13 | €21k |
| Amounts payable | 17/49 | €45k |
| Amounts payable after one year | 17 | €26k |
| Amounts payable within one year | 42/48 | €19k |
| Trade debts payable within one year | 44 | €731 |
| Income statement | ||
| Gross operating margin | 9900 | €30k |
| Operating result | 9901 | €16k |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €13k |
| Income taxes | 67/77 | €4k |
| Net result for the period | 9904 | €9k |
| Result to be appropriated | 9905 | €9k |
| NACE primary | 85699 |
| Legal form | Private limited company(610) |
| Incorporation | 24-02-2021 |
| Status | Active |
| Postal code | 1850 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23025B0094/00T002 | Flanders | 380 m² | 1 · 106 m² | 9.9 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
17-01-2023 All shares are now held by a single shareholder
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inkoop_eigen_aandelen",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "agio_incorporation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "withdrawal_redemption",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "merger_share_issue",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "loss_absorption_only",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Luik",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2023-01-09",
"act_kind_objet": "Onderwerp akte: Verening van Alle Aandelen in 1 Hand - Volmacht - Ontslag Bestuurder - Wijziging Zetel - Volmacht"
},
"decision": {
"body": "eenig_aandeelhouder_schriftelijk",
"act_date": "2023-01-23",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2022-12-14"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0763.983.282",
"name_full": "PHYSIOVISIT",
"legal_form": "Besloten Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Fidiaz NV",
"person_name": "Kristof Kennis",
"org_rep_person_name": "Kristof Kennis",
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | PHYSIOVISIT |